Litchev Boyan Vesselinov's Form 4 filing
Indaptus Therapeutics, Inc. (INDP) · filed Dec 19, 2022
- Accession no.
- 0001493152-22-035926
- Filed
- Dec 19, 2022
- Trade date
- Jan 31-Dec 1, 2022
- Filing delay
- 322 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.52K. It was filed 322 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Litchev Boyan VesselinovCIK 0001902726 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Common Stock | PPurchaseAcquired | +100 | $4.65 | +$465 | 100 | Direct | |
| Mar 2, 2022 | Common Stock | PPurchaseAcquired | +50 | $4.09 | +$204.5 | 150 | Direct | |
| Nov 22, 2022 | Common Stock | PPurchaseAcquired | +500 | $1.83 | +$915 | 650 | Direct | |
| Dec 1, 2022 | Common Stock | PPurchaseAcquired | +500 | $1.87 | +$935 | 1,150 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.